Knotless Tissue Repair and Attachment Devices

Slides:



Advertisements
Similar presentations
Engaging with Industry 5th NIHR Trainee Meeting Dr Ceri Williams – Director of Operations Innovation and Knowledge Centre in Regenerative Therapies and.
Advertisements

Shareholders Meeting August 22, 2013 CONFIDENTIAL1.
Title Slide – Technology Name Presenter’s Information and Title Title of Industry Contacts and University Contacts (as applicable) **IMPORTANT INSTRUCTIONS:
2014 Annual Meeting of Stockholders Dan Moore, President & Chief Executive Officer September 18, 2014.
Orteq is a fast-growing medical device company with a groundbreaking biocompatible polymer platform focused on treating orthopaedic sports injuries. Orteq’s.
New Technique in Shoulder Surgery for Sports Injury Dennis Crawford MD, PhD Assistant Professor Surgical Director, Sports Medicine Program Department of.
Strengthening the Medical Device Clinical Trial Enterprise
Coen A. Wijdicks, Ph.D. Chief Operating Officer Director of the Department of BioMedical Engineering Senior Staff Scientist Steadman.
Introduction to Global Marketing
Medical Device Idea Generation Fred B. Dinger, III President & CEO ENTrigue Surgical and C2M Medical Stanford Taiwan Biomedical Conference September 2008.
Joseph S. Park, M.D. Silvia Blemker, PhD. University of Virginia Orthopaedic Surgery Clinical Problem: Fixation of FDL Tendon to Navicular Cut posterior.
FDA Regulation of Combination Products Barbara D. Boyan, Ph.D. American Academy of Orthopaedic Surgeons Professor and Deputy Director for Research for.
Careers in Biomedical Engineering Technology BMET 4350 Fall 2003 Dr. Hugh Blanton.
BIOME ™ : Bio Innovations and Opportunities in Medicine and Engineering Robert G. Radwin, Professor & Chair, Biomedical Engineering Lawrence A. Casper,
Introducing New Techniques and New Technologies: Role of the BOA Code of Ethics Gordon Bannister Professor of Orthopaedic Surgery University of Bristol.
Pharma.be The Initiative to Promote Clinical Trials in Belgium Key Performance Indicators: Impact on Clinical Research of European Legislation Square –
“Paying for clinical trials with an SBIR grant” Our experience obtaining millions of dollars through the NIH's Phase II Competing Renewal program Adapted.
Regulatory Problems Moderators: Eugene Chen and Michael Kochman, MD.
1 The Lockheed Martin India Innovation Growth Program
IGEM Project Technology Name Presenter’s Information and Title Title of Industry Contacts and University Contacts.
Shoulder Instability and the Role of PT/OT Derek Cuff, M.D. Suncoast Orthopaedic Surgery and Sports Medicine.
Update On The ERO Transition Activities To Comply With The 2005 EPAC ERCOT TAC Meeting March 9, 2006 Sam Jones, COO.
DIA 6 th European Validation Workshop, Amsterdam, Building Change into Process David Bridges Director, eChange Solutions Limited.
Load-to-Failure, Contact Area and Contact Pressure of Three Rotator Cuff Repair Methods: A Comparative Biomechanical Analysis Josianne Lépine and Frédéric.
Innovation Acceleration Partner Fellows Program Approaches to Improving Commercialization and Innovation National Science Foundation Partner for Innovation.
Medical Device R&D / manufacturing in Mexico for worldwide markets Summary of Technical Capabilities ZIPTEK MEXICO SA DE CV.
THE PROBLEM: CURRENT CONTINUOUS GLUCOSE MONITORS (CGM) ARE INVASIVE Continuous glucose monitoring is critical for some diabetics and very advantageous.
Protection of Intellectual Property in Canada George Jackowski, Ph.D., KCTJ October 19 th, 2015 Chairman of NAVA Corp.
Intellectual Property at USC October 27, 2003 Dr. Michael Muthig.
Clinical Engagement: Who? When? Why? POOJA KADAMBI SYSTEMS DESIGN ENGINEER- INNACCEL CAMTECH BOOTCAMP 2016.
Introduction to Carilex Medical. Overview  Manufacturer and designer of OEM and Carilex-branded wound care products o Specializing in therapeutic support.
Canada Sterilization Equipment Market Outlook to 2021.
Regulatory Intelligence for the Emerging Markets Lisa Rysso-DeMaggio President, RAQUELIAN Consulting DIA Regulatory Intelligence Working Group, 10 Sep.
ICORD 2006 Kerstin Westermark Md, PhD, Assoc. prof. COMP Chairperson.
Social Media Analytics Market to Global Analysis and Forecast by Type, Application and Vertical No of Pages: 150 Publishing Date: Jan 2017 Single.
Social Media Analytics Market to Global Analysis and Forecast by Type, Application and Vertical No of Pages: 150 Publishing Date: Feb 2017 Single.
Visualization and 3D Rendering Software Market to Global Analysis and Forecast by Application, by Deployment Type and by End User No of Pages: 150.
EphMRA/PBIRG Classification Committee WHO WE ARE. WHAT WE DO. 2017
Southeast Region Technology Transfer Directors Meeting July 13, 2012
Regulatory Basics: Europe and the CE Mark
Title Arrow Cloud NOTE: Remember to update name on slide.
Developing and Managing Products
OUS Data: What does the CE Mark Really Mean?
Arthroscopic Bankart Reconstruction
The Current PMA Requirements
IHE Eye Care Process and Timeline
What Kind of Aspects can Physicians Look Forward To? US Physician View
General Inventions, LLC
Your Name, Founder, CEO Address Cell phone
Global Orthopedic Soft Tissue Repair and Sports Medicine Market Is Estimated to Reach $13 Billion By 2024, Says Variant Market Research Bhavana Patel SEO.
NEW PRODUCT DEVELOPMENT
NEW PRODUCT DEVELOPMENT
Presented to IEEE Standards Education Committee 11 April 2014
IMPI’s Role in the International Arena
APICS Chapter innovation fund
International Network Affiliate Fee Share Operating Model
Knotless Tissue Repair and Attachment Devices
Outlook for Orthopedics
Knotless Tissue Repair and Attachment Devices
© 2018 Global Market Insights, Inc. USA. All Rights Reserved Drug Integrated Polymer Fibers Market report for 2025 – Companies, applications,
Natural Gas Innovation Fund Investment Intake Template Project Title Submitted By *Note: This template is intended as a guide on content; you may.
Rotator Cuff Rehab: Where are we in 2018?
The Surgeon-Therapist Relationship
Opening an IND: Investigator Perspective
Expanding Indications of Reverse Shoulder Arthroplasty
Bioabsorbable Surgical Clip & Applicator Commercialization
Accelerating Technology for the Securities Token Revolution
Natural Gas Innovation Fund Investment Intake Template
Arthroscopy Instruments Market is expected to Grow at CAGR of 6.5 % during the forecast period of 2019– 2023 PREPARED BY Market Research Future (Part of.
Global Specialty Pharmaceuticals Market. Report Description and Highlights According to Renub Research report "Specialty Pharmaceuticals Market, by Country.
Presentation transcript:

Knotless Tissue Repair and Attachment Devices 1250 S. Tamiami Trail Suite 303 Sarasota, FL 34239 US www.ziptekglobal.com

Knotless Tissue Repair and Attachment Devices $5,000,000 Series “A” Offering Contingent on FDA Approval 510k Filed-Completed First Review Providing Requested Additional Information R Knotless Tissue Repair and Attachment Devices Patent # 9307979

What Does Make? The is a registered trademark Patented! The ZipE® is a surgical button or “capture” that slides along a suture with protuberances in a forward direction and is prevented from moving backwards along its path, similar to a Zip-Tie, and is the backbone of the technology platform for Ziptek’s knotless tissue repair devices and is used for tissue-to-tissue and tissue-to-bone repair. The U.S. Soft Tissue Repair Market, per annum, is about $2-3 billion. The is a registered trademark Patented! Initially focused on Rotator Cuff Repair Market There are over 21 other Indications For Use(IFUs) filed with the FDA application

Whether knotted or knotless Most Common form of failure is rip through Traditional Suture vs ZipE® Repair The Advantage ZipE® Tissue Repair Traditional Tissue Repair Whether knotted or knotless Most Common form of failure is rip through Increased contact surface area for lower failure rates Prevents rip through Like Tying a Bow Like a Carpet Floor Tack

The ® Advantage! Suture Ripthrough-Traditional Repair ZipE® Capture Stabilization All devices on the market suffer from high rates of failure due to rip through. This video shows how the ZipE® stabilizes the tissue, helps prevent this form of failure, and creates increased contact surface area allowing for improved tissue healing. The rate of non-healing and re-tears can be higher than 60%, or about a $300 million/year U.S. expenditure on failed rotator cuff surgery.

Patents 7 Patents Issued 3 More Expected Within 6-12 Months 11 Countries plus E.U.(28)- Patentable Material Filed 2 Foreign Patents Have Already Been Issued Patent # 9307979

Patent Pending-Patentable WIPO* -Driver* -Method* -Screw* Multi-Purpose Driver Capture Holster Capture Pusher Our other patents open up additional realms for further applications -special screws -driver *Deemed patentable by WIPO-filed in 11 countries plus E.U.(28)

ZipE® Surgical Procedure Steps

Safety and Performance Testing Certification Status Biocompatibility 21 CFR Part 58 Compliance   Good Laboratory Practice for Nonclinical / Lab Studies ISO 10993-13 tests Passed Performance testing Biomechanical- static and cyclic loading USP 39-NF 33:2016 <881> Tensile Strength Degradation Studies ASTM F1635 Sterilization Validation ISO 11135 EO Residuals Shelf life -post accelerated aging ASTM F1980 Passed* ASTM 2096 – 11 Seal Package Validation ISO 11607 -1:2006 ASTM F88/F88M-15 Finalizing bubble burst testing Specific testing categories that have been performed and passed include: *1 year passed

William F Bennett MD Orthopedic Surgeon Founder Bio 20-plus years of experience with rotator cuff repair and knotless devices Significant Intellectual Property- -one of the earliest to file -and a market driving factor Early arthroscopic rotator cuff repair specialist -developed and published surgical techniques, classification systems and outcome studies Numerous issued patents and publications in this domain Started Ziptek Mexico Sa De Cv! -with Professor Ramses Galaz PhD Biomedical Engineer, -partner both Ziptek LLC and Ziptek Mexico Sa De Cv Ziptek Mexico Sa De Cv has won multiple Grants enabling Ziptek LLC to accelerate further product design 2nd and 3rd generation products in development Preparing for “Biologics” integration Dr. Bennett CV Hermosillo, Sonora, Mexico

Concept to Market 20 years 510k FDA Application Filed! Aug 2016 New Patents Issued 1995 2000 2010 2020 2017 New patents Filed Ziptek Funded 2014 R 3 PATENTS Issued 2000-2003 Decision To Commercialize 2009 First business plan Ziptek LLC Incorporated 2012 Market Entry! FDA Approval Expected late 1st Or early 2nd quarter Capture idea born! First knotless Patent Application filed, May 1995 Testing Completed Passed Biocompatibility Performance Testing Degradation Studies Package Validation Sterilization Validation EO Residuals Shelf Life Trademark accepted By the FDA-2016 Negotiated Operational Agreement with Mexican Biomed engineer, PhD and partner 2010 According to data from the Journal of the American Academy of Orthopedic Surgeons, with FDA approval In January, 2017, Ziptek will have achieved this milestone using 1/30th of average cost to get approval!!

Why Invest? ZipE® -is a disruptive and complementary technology platform -only device that prevents rip through- the highest failure mode found with other devices on the market -multiple Indications For Use (IFU~21) -multiple device pipelines -multiple surgical disciplines U.S. Soft Tissue Repair Market- ~2-3 Billion per year U.S. Rotator Cuff ~500,000 reimbursed surgical cases Ankle Ligament- ~1-2,000,000 injuries/year ZipE® Engineering is One of a Kind! 2.5:1 force ratio! Ratio same/ scaleable by size for other IFUs

Why Invest? Patent language covers indications outside of orthopedics - -Patentable material filed in 11 Countries plus E.U.(28) Ziptek Mexico Sa De Cv- Mexican support company -Founder William F Bennett MD- Sonora, Mexico Ziptek LLC is positioning itself for rapid growth- by introducing ZipE® to Surgeons through orthopedic research projects -Florida Orthopedic Training program- contact area cadaveric study-started -Mexico’s Federal Orthopedic Program– sheep model healing -Colorado Orthopedic Training and Research Foundation- sheep model vascularity -European Groups-Worldwide Distribution network- wants samples-validate

Why Invest in Us? At the Recent 2016 AAOS Annual Meeting This is a sample of distributors who want to be notified with FDA Approval

care of rotator cuff repair. Orthopedic Sports Surgeon Testimonial Sample Dubai William. D. Murrell, Jr., M.D. Shoulder and Sports Surgeon I have worked with Bill on worldwide distribution planning for the Ziptek implant. In my opinion, also being a primary shoulder surgeon, the device should revolutionize the care of rotator cuff repair. Consultant Orthopaedic Sports Medicine DHBMC Dubai, United Arab Emirates USA Canada Don Johnson M.D. Orthopedic Sports Surgeon I have reviewed the product that Bill has been developing the past couple of years, and feel that it has great potential to be a significant improvement in the knotless anchor sphere. Director, Sports Medicine Clinic Carleton University (colleague) Marcos V. Masson M.D. Shoulder Surgeon I have looked at the patents, the prototypes and the technique-the key is simplicity- with the avoidance of knot tying more surgeons will adopt the technique.

A New Funding Round Allows for -rapid growth with interested national and international parties -buildout of infrastructure, to include key sales force executives -the development of a regional inventory -for the rapid introduction to Surgeons at meetings, by exhibiting, by sponsoring and training -the continued prosecution of ongoing patent and foreign regulatory approval -for a robust Global “Work-Around”patent that is presently pending at WIPO $30,000,000 30 20 10 2017 2018 2019 2020 Revenue in Millions(US Dollars)

$5,000,000 Series “A” Offering Filed to FDA August 2016 Completed First Review Providing Requested Additional Information *FDA Approval Contingency for Funding *With Ziptek’s FDA Approval this milestone will be achieved at ~1/30th the average cost for other 510k approvals Thank You!

Ziptek Surgical Brochure Photo Time! www.ziptekglobal.com Investor Intro Letter Ziptek Surgical Brochure Management